BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 15064146)

  • 1. Involvement of vanilloid-like receptors in the effects of anandamide on motor behavior and nigrostriatal dopaminergic activity: in vivo and in vitro evidence.
    de Lago E; de Miguel R; Lastres-Becker I; Ramos JA; Fernández-Ruiz J
    Brain Res; 2004 May; 1007(1-2):152-9. PubMed ID: 15064146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypolocomotor effects in rats of capsaicin and two long chain capsaicin homologues.
    Di Marzo V; Lastres-Becker I; Bisogno T; De Petrocellis L; Milone A; Davis JB; Fernandez-Ruiz JJ
    Eur J Pharmacol; 2001 May; 420(2-3):123-31. PubMed ID: 11408034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time-course of the effects of anandamide, the putative endogenous cannabinoid receptor ligand, on extrapyramidal function.
    Romero J; de Miguel R; García-Palomero E; Fernández-Ruiz JJ; Ramos JA
    Brain Res; 1995 Oct; 694(1-2):223-32. PubMed ID: 8974649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endocannabinoids activate transient receptor potential vanilloid 1 receptors to reduce hyperdopaminergia-related hyperactivity: therapeutic implications.
    Tzavara ET; Li DL; Moutsimilli L; Bisogno T; Di Marzo V; Phebus LA; Nomikos GG; Giros B
    Biol Psychiatry; 2006 Mar; 59(6):508-15. PubMed ID: 16199010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The endogenous cannabinoid receptor ligand, anandamide, inhibits the motor behavior: role of nigrostriatal dopaminergic neurons.
    Romero J; García L; Cebeira M; Zadrozny D; Fernández-Ruiz JJ; Ramos JA
    Life Sci; 1995; 56(23-24):2033-40. PubMed ID: 7776829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anandamide excites central terminals of dorsal root ganglion neurons via vanilloid receptor-1 activation.
    Tognetto M; Amadesi S; Harrison S; Creminon C; Trevisani M; Carreras M; Matera M; Geppetti P; Bianchi A
    J Neurosci; 2001 Feb; 21(4):1104-9. PubMed ID: 11160380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis.
    Cabranes A; Venderova K; de Lago E; Fezza F; Sánchez A; Mestre L; Valenti M; García-Merino A; Ramos JA; Di Marzo V; Fernández-Ruiz J
    Neurobiol Dis; 2005 Nov; 20(2):207-17. PubMed ID: 16242629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anandamide and methanandamide induce both vanilloid VR1- and cannabinoid CB1 receptor-mediated changes in heart rate and blood pressure in anaesthetized rats.
    Malinowska B; Kwolek G; Göthert M
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Dec; 364(6):562-9. PubMed ID: 11770012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compounds acting at the endocannabinoid and/or endovanilloid systems reduce hyperkinesia in a rat model of Huntington's disease.
    Lastres-Becker I; de Miguel R; De Petrocellis L; Makriyannis A; Di Marzo V; Fernández-Ruiz J
    J Neurochem; 2003 Mar; 84(5):1097-109. PubMed ID: 12603833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide.
    Zygmunt PM; Petersson J; Andersson DA; Chuang H; Sørgård M; Di Marzo V; Julius D; Högestätt ED
    Nature; 1999 Jul; 400(6743):452-7. PubMed ID: 10440374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presynaptic facilitation of glutamatergic synapses to dopaminergic neurons of the rat substantia nigra by endogenous stimulation of vanilloid receptors.
    Marinelli S; Di Marzo V; Berretta N; Matias I; Maccarrone M; Bernardi G; Mercuri NB
    J Neurosci; 2003 Apr; 23(8):3136-44. PubMed ID: 12716921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine activation of endogenous cannabinoid signaling in dorsal striatum.
    Giuffrida A; Parsons LH; Kerr TM; Rodríguez de Fonseca F; Navarro M; Piomelli D
    Nat Neurosci; 1999 Apr; 2(4):358-63. PubMed ID: 10204543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of anandamide-induced vasorelaxation in rat isolated coronary arteries.
    White R; Ho WS; Bottrill FE; Ford WR; Hiley CR
    Br J Pharmacol; 2001 Oct; 134(4):921-9. PubMed ID: 11606334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of trigeminal sensory neuron activity by the dual cannabinoid-vanilloid agonists anandamide, N-arachidonoyl-dopamine and arachidonyl-2-chloroethylamide.
    Price TJ; Patwardhan A; Akopian AN; Hargreaves KM; Flores CM
    Br J Pharmacol; 2004 Apr; 141(7):1118-30. PubMed ID: 15006899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anandamide-induced behavioral disruption through a vanilloid-dependent mechanism in rats.
    Panlilio LV; Mazzola C; Medalie J; Hahn B; Justinova Z; Drago F; Cadet JL; Yasar S; Goldberg SR
    Psychopharmacology (Berl); 2009 Apr; 203(3):529-38. PubMed ID: 19015836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors.
    Golech SA; McCarron RM; Chen Y; Bembry J; Lenz F; Mechoulam R; Shohami E; Spatz M
    Brain Res Mol Brain Res; 2004 Dec; 132(1):87-92. PubMed ID: 15548432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anandamide improves the impaired nitric oxide-mediated neurogenic relaxation of the corpus cavernosum in diabetic rats: involvement of cannabinoid CB1 and vanilloid VR1 receptors.
    Ghasemi M; Sadeghipour H; Dehpour AR
    BJU Int; 2007 Dec; 100(6):1385-90. PubMed ID: 17850365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-acyldopamines control striatal input terminals via novel ligand-gated cation channels.
    Ferreira SG; Lomaglio T; Avelino A; Cruz F; Oliveira CR; Cunha RA; Köfalvi A
    Neuropharmacology; 2009 Mar; 56(3):676-83. PubMed ID: 19101577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of rimonabant, a selective cannabinoid CB1 receptor antagonist, in a rat model of Parkinson's disease.
    González S; Scorticati C; García-Arencibia M; de Miguel R; Ramos JA; Fernández-Ruiz J
    Brain Res; 2006 Feb; 1073-1074():209-19. PubMed ID: 16412990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anandamide regulates neuropeptide release from capsaicin-sensitive primary sensory neurons by activating both the cannabinoid 1 receptor and the vanilloid receptor 1 in vitro.
    Ahluwalia J; Urban L; Bevan S; Nagy I
    Eur J Neurosci; 2003 Jun; 17(12):2611-8. PubMed ID: 12823468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.